Resilience in Neurodegeneration: Prilenia’s Journey in Huntington’s Disease Drug Development
In this episode of The Life Science Insider, Kieran Canisius speaks with Limor Ben Har, COO of Prilenia Therapeutics, about what it takes to lead through complexity. Together they unpack the true meaning of biotech resilience - how a science-driven, patient-focused team turned unexpected data into a strategic partnership and renewed momentum.
Limor offers candid insight into neurodegenerative development, market expectations, and the power of staying mission-aligned through it all.
🎧 Subscribe to The Life Science Insider and follow Seuss+ for more behind-the-scenes biotech leadership stories.
Cut the Chat Life Science Insider
An informative podcast series designed quite literally cut the unnecessary talk and get straight to the point and heart of many life science and Biotech conversations that need to happen for our industry to evolve, innovate and get smarter—faster.
We’ll facilitate the conversations you’ve been dying to hear and tackle the real crux of our industry’s challenges while addressing the subjects of what we can do as life science leaders to be more successful in a shorter period of time, conversations that might actually help each other when we dare to open up.
Hear directly from some visionary global biotech and life science leaders.
- No. of episodes: 11
- Latest episode: 2025-06-19
- Science Life Sciences
Where can you listen?
